品牌 | 货号 | 包装单位 | 货期 | CAS | 产品名称 | 质量规格 | 单价(¥) | 购买数量 |
---|---|---|---|---|---|---|---|---|
罗恩 | R020384-25mg | 25mg | 5~7个工作日 | 639089-54-6 |
陶扎色替 Tozaserti |
98% |
|
|
罗恩 | R020384-100mg | 100mg | 5~7个工作日 | 639089-54-6 |
陶扎色替 Tozaserti |
98% |
|
|
麦克林 | T863610-25mg | 25mg | 现货 | 639089-54-6 |
Tozasertib Tozaserti 干冰运输(加收30元干冰费用) |
≥98% |
|
|
麦克林 | T863610-5mg | 5mg | 现货 | 639089-54-6 |
Tozasertib Tozaserti 干冰运输(加收30元干冰费用) |
≥98% |
|
|
麦克林 | T796034-1ml | 1ml | 10个工作日 | 639089-54-6 |
Tozasertib Tozaserti 干冰运输(加收30元干冰费用) |
10mM in DMSO |
|
|
阿拉丁 | T127762-25mg | 25mg | 现货 | 639089-54-6 |
陶扎色替 Tozaserti |
Moligand™, ≥98% |
|
|
阿拉丁 | T127762-100mg | 100mg | 现货 | 639089-54-6 |
陶扎色替 Tozaserti |
Moligand™, ≥98% |
|
|
阿拉丁 | T407973-1ml | 1ml | 现货 | 639089-54-6 |
Tozasertib (VX-680, MK-0457) Tozasertib (VX-680, MK-0457) |
Moligand™, 10mM in DMSO |
|
|
毕得 | BD161453-25mg | 25mg | 现货 | 639089-54-6 |
N-(4-((4-((5-甲基-1H-吡唑-3-基)氨基... N-(4-((4-((5-Methyl-1H-pyraz... |
99+% |
|
|
毕得 | BD161453-50mg | 50mg | 现货 | 639089-54-6 |
N-(4-((4-((5-甲基-1H-吡唑-3-基)氨基... N-(4-((4-((5-Methyl-1H-pyraz... |
99+% |
|
|
毕得 | BD161453-100mg | 100mg | 现货 | 639089-54-6 |
N-(4-((4-((5-甲基-1H-吡唑-3-基)氨基... N-(4-((4-((5-Methyl-1H-pyraz... |
99+% |
|
|
毕得 | BD161453-250mg | 250mg | 现货 | 639089-54-6 |
N-(4-((4-((5-甲基-1H-吡唑-3-基)氨基... N-(4-((4-((5-Methyl-1H-pyraz... |
99+% |
|
|
毕得 | BD161453-5mg | 5mg | 现货 | 639089-54-6 |
N-(4-((4-((5-甲基-1H-吡唑-3-基)氨基... N-(4-((4-((5-Methyl-1H-pyraz... |
99+% |
|
|
毕得 | BD161453-10mg | 10mg | 现货 | 639089-54-6 |
N-(4-((4-((5-甲基-1H-吡唑-3-基)氨基... N-(4-((4-((5-Methyl-1H-pyraz... |
99+% |
|
|
毕得 | BD161453-1g | 1g | 现货 | 639089-54-6 |
N-(4-((4-((5-甲基-1H-吡唑-3-基)氨基... N-(4-((4-((5-Methyl-1H-pyraz... |
99+% |
|
|
源叶 | S49418-25mg | 25mg | 现货 | 639089-54-6 |
Tozasertib Tozaserti |
≥98% |
|
|
源叶 | S49418-100mg | 100mg | 现货 | 639089-54-6 |
Tozasertib Tozaserti |
≥98% |
|
|
源叶 | T98824-1ml | 1ml | 期货,请咨询 | 639089-54-6 |
Tozasertib (VX-680, MK-0457) Tozasertib (VX-680, MK-0457) |
10mM in DMSO |
|
|